nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Citrulline—DDAH2—hypertension	0.294	0.388	CbGaD
L-Citrulline—DDAH1—hypertension	0.294	0.388	CbGaD
L-Citrulline—NOS1—hypertension	0.0824	0.109	CbGaD
L-Citrulline—NOS3—hypertension	0.0448	0.0591	CbGaD
L-Citrulline—NOS2—hypertension	0.0433	0.0571	CbGaD
L-Citrulline—NOS3—femoral artery—hypertension	0.00775	0.0803	CbGeAlD
L-Citrulline—NOS3—thoracic aorta—hypertension	0.00721	0.0746	CbGeAlD
L-Citrulline—NOS1—arteriole—hypertension	0.00618	0.064	CbGeAlD
L-Citrulline—NOS3—middle cerebral artery—hypertension	0.00533	0.0552	CbGeAlD
L-Citrulline—NOS3—arteriole—hypertension	0.0047	0.0486	CbGeAlD
L-Citrulline—NOS3—tunica intima—hypertension	0.00333	0.0345	CbGeAlD
L-Citrulline—NOS3—pulmonary artery—hypertension	0.00308	0.0319	CbGeAlD
L-Citrulline—NOS3—vein—hypertension	0.0028	0.029	CbGeAlD
L-Citrulline—NOS3—nephron—hypertension	0.00204	0.0212	CbGeAlD
L-Citrulline—DDAH1—endothelium—hypertension	0.0019	0.0196	CbGeAlD
L-Citrulline—NOS3—hindlimb—hypertension	0.00186	0.0193	CbGeAlD
L-Citrulline—DDAH1—blood vessel—hypertension	0.00175	0.0181	CbGeAlD
L-Citrulline—PADI1—decidua—hypertension	0.00171	0.0177	CbGeAlD
L-Citrulline—NOS1—artery—hypertension	0.0015	0.0155	CbGeAlD
L-Citrulline—Carglumic Acid—CPS1—hypertension	0.00135	0.219	CrCbGaD
L-Citrulline—DDAH2—cardiac ventricle—hypertension	0.00131	0.0135	CbGeAlD
L-Citrulline—NOS1—endothelium—hypertension	0.00127	0.0131	CbGeAlD
L-Citrulline—DDAH1—cardiac ventricle—hypertension	0.00126	0.013	CbGeAlD
L-Citrulline—DDAH2—myocardium—hypertension	0.00123	0.0127	CbGeAlD
L-Citrulline—DDAH1—myocardium—hypertension	0.00118	0.0123	CbGeAlD
L-Citrulline—NOS1—blood vessel—hypertension	0.00117	0.0121	CbGeAlD
L-Citrulline—NOS3—artery—hypertension	0.00114	0.0118	CbGeAlD
L-Citrulline—NOS2—adrenal gland—hypertension	0.00114	0.0118	CbGeAlD
L-Citrulline—NOS3—endothelium—hypertension	0.000963	0.00998	CbGeAlD
L-Citrulline—DDAH2—nephron tubule—hypertension	0.000901	0.00933	CbGeAlD
L-Citrulline—OTC—adrenal gland—hypertension	0.000898	0.0093	CbGeAlD
L-Citrulline—NOS3—blood vessel—hypertension	0.000889	0.0092	CbGeAlD
L-Citrulline—PADI4—endocrine gland—hypertension	0.000887	0.00919	CbGeAlD
L-Citrulline—DDAH2—adrenal cortex—hypertension	0.000887	0.00918	CbGeAlD
L-Citrulline—DDAH1—nephron tubule—hypertension	0.000869	0.009	CbGeAlD
L-Citrulline—DDAH2—heart—hypertension	0.000857	0.00888	CbGeAlD
L-Citrulline—PADI3—central nervous system—hypertension	0.000855	0.00885	CbGeAlD
L-Citrulline—DDAH2—decidua—hypertension	0.000834	0.00864	CbGeAlD
L-Citrulline—DDAH1—heart—hypertension	0.000827	0.00856	CbGeAlD
L-Citrulline—DDAH1—smooth muscle tissue—hypertension	0.00082	0.00849	CbGeAlD
L-Citrulline—DDAH1—decidua—hypertension	0.000804	0.00833	CbGeAlD
L-Citrulline—PADI4—central nervous system—hypertension	0.000799	0.00828	CbGeAlD
L-Citrulline—DDAH1—cardiovascular system—hypertension	0.00078	0.00808	CbGeAlD
L-Citrulline—OTC—endocrine gland—hypertension	0.000779	0.00807	CbGeAlD
L-Citrulline—DDAH2—cortex of kidney—hypertension	0.000771	0.00798	CbGeAlD
L-Citrulline—DDAH1—kidney—hypertension	0.000763	0.00791	CbGeAlD
L-Citrulline—DDAH1—cortex of kidney—hypertension	0.000743	0.0077	CbGeAlD
L-Citrulline—DDAH2—cardiac atrium—hypertension	0.000733	0.00759	CbGeAlD
L-Citrulline—OTC—central nervous system—hypertension	0.000702	0.00727	CbGeAlD
L-Citrulline—DDAH2—medulla oblongata—hypertension	0.000691	0.00716	CbGeAlD
L-Citrulline—PADI2—endocrine gland—hypertension	0.000662	0.00686	CbGeAlD
L-Citrulline—ASS1—cardiac ventricle—hypertension	0.000642	0.00665	CbGeAlD
L-Citrulline—DDAH2—adrenal gland—hypertension	0.00064	0.00663	CbGeAlD
L-Citrulline—NOS3—cardiac ventricle—hypertension	0.00064	0.00663	CbGeAlD
L-Citrulline—NOS1—brainstem—hypertension	0.000639	0.00662	CbGeAlD
L-Citrulline—DDAH1—adrenal gland—hypertension	0.000617	0.00639	CbGeAlD
L-Citrulline—ASS1—myocardium—hypertension	0.000604	0.00625	CbGeAlD
L-Citrulline—NOS3—myocardium—hypertension	0.000602	0.00623	CbGeAlD
L-Citrulline—PADI2—central nervous system—hypertension	0.000597	0.00618	CbGeAlD
L-Citrulline—NOS1—heart—hypertension	0.000553	0.00572	CbGeAlD
L-Citrulline—Glutathione—GSTA5—hypertension	0.000548	0.0886	CrCbGaD
L-Citrulline—NOS1—smooth muscle tissue—hypertension	0.000548	0.00568	CbGeAlD
L-Citrulline—DDAH1—endocrine gland—hypertension	0.000535	0.00554	CbGeAlD
L-Citrulline—NOS1—cardiovascular system—hypertension	0.000521	0.0054	CbGeAlD
L-Citrulline—NOS1—kidney—hypertension	0.00051	0.00528	CbGeAlD
L-Citrulline—NOS1—cortex of kidney—hypertension	0.000497	0.00515	CbGeAlD
L-Citrulline—DDAH1—central nervous system—hypertension	0.000482	0.00499	CbGeAlD
L-Citrulline—NOS1—medulla oblongata—hypertension	0.000445	0.00461	CbGeAlD
L-Citrulline—ASS1—nephron tubule—hypertension	0.000443	0.00459	CbGeAlD
L-Citrulline—ASS1—adrenal cortex—hypertension	0.000436	0.00451	CbGeAlD
L-Citrulline—ASS1—heart—hypertension	0.000421	0.00436	CbGeAlD
L-Citrulline—NOS3—heart—hypertension	0.00042	0.00435	CbGeAlD
L-Citrulline—L-Ornithine—ARG1—hypertension	0.000419	0.0678	CrCbGaD
L-Citrulline—ASS1—smooth muscle tissue—hypertension	0.000418	0.00433	CbGeAlD
L-Citrulline—NOS3—smooth muscle tissue—hypertension	0.000417	0.00432	CbGeAlD
L-Citrulline—Glutathione—GSTM5—hypertension	0.000416	0.0671	CrCbGaD
L-Citrulline—ASS1—decidua—hypertension	0.00041	0.00424	CbGeAlD
L-Citrulline—ASS1—cardiovascular system—hypertension	0.000398	0.00412	CbGeAlD
L-Citrulline—NOS3—cardiovascular system—hypertension	0.000396	0.00411	CbGeAlD
L-Citrulline—ASS1—kidney—hypertension	0.000389	0.00403	CbGeAlD
L-Citrulline—NOS3—kidney—hypertension	0.000388	0.00402	CbGeAlD
L-Citrulline—ASS1—cortex of kidney—hypertension	0.000379	0.00392	CbGeAlD
L-Citrulline—ASS1—cardiac atrium—hypertension	0.00036	0.00373	CbGeAlD
L-Citrulline—NOS1—endocrine gland—hypertension	0.000358	0.0037	CbGeAlD
L-Citrulline—L-Cysteine—CDO1—hypertension	0.000347	0.0561	CrCbGaD
L-Citrulline—ASS1—medulla oblongata—hypertension	0.00034	0.00352	CbGeAlD
L-Citrulline—NOS1—central nervous system—hypertension	0.000322	0.00334	CbGeAlD
L-Citrulline—ASS1—adrenal gland—hypertension	0.000315	0.00326	CbGeAlD
L-Citrulline—NOS3—adrenal gland—hypertension	0.000314	0.00325	CbGeAlD
L-Citrulline—L-Glutamine—GLS2—hypertension	0.0003	0.0484	CrCbGaD
L-Citrulline—L-Serine—CBS—hypertension	0.000281	0.0453	CrCbGaD
L-Citrulline—L-Arginine—ARG2—hypertension	0.000276	0.0445	CrCbGaD
L-Citrulline—ASS1—endocrine gland—hypertension	0.000273	0.00282	CbGeAlD
L-Citrulline—NOS3—endocrine gland—hypertension	0.000272	0.00282	CbGeAlD
L-Citrulline—Glutathione—GPX3—hypertension	0.000268	0.0433	CrCbGaD
L-Citrulline—ASS1—central nervous system—hypertension	0.000246	0.00255	CbGeAlD
L-Citrulline—NOS3—central nervous system—hypertension	0.000245	0.00254	CbGeAlD
L-Citrulline—L-Cysteine—CBS—hypertension	0.000224	0.0361	CrCbGaD
L-Citrulline—L-Ornithine—ARG2—hypertension	0.00022	0.0356	CrCbGaD
L-Citrulline—Glutathione—GPX1—hypertension	0.000197	0.0318	CrCbGaD
L-Citrulline—L-Cysteine—GCLC—hypertension	0.000182	0.0294	CrCbGaD
L-Citrulline—L-Glutamine—TGM2—hypertension	0.000181	0.0293	CrCbGaD
L-Citrulline—L-Aspartic Acid—GOT2—hypertension	0.000176	0.0285	CrCbGaD
L-Citrulline—L-Cysteine—GOT1—hypertension	0.000138	0.0223	CrCbGaD
L-Citrulline—L-Aspartic Acid—GOT1—hypertension	0.000134	0.0216	CrCbGaD
L-Citrulline—L-Arginine—NOS3—hypertension	0.000106	0.0171	CrCbGaD
L-Citrulline—L-Arginine—NOS2—hypertension	0.000102	0.0165	CrCbGaD
L-Citrulline—Glutathione—GSTT1—hypertension	9.27e-05	0.015	CrCbGaD
L-Citrulline—Glutathione—ABCC1—hypertension	8.99e-05	0.0145	CrCbGaD
L-Citrulline—Glutathione—GSTM1—hypertension	7.92e-05	0.0128	CrCbGaD
L-Citrulline—L-Methionine—MTHFR—hypertension	6.13e-05	0.0099	CrCbGaD
L-Citrulline—NOS3—Metabolism—GOT2—hypertension	6.62e-06	4.75e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—CCR5—hypertension	6.56e-06	4.71e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—PRKCD—hypertension	6.56e-06	4.71e-05	CbGpPWpGaD
L-Citrulline—NOS1—Disease—AKT2—hypertension	6.53e-06	4.69e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—NCF2—hypertension	6.51e-06	4.67e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—ADRA2A—hypertension	6.48e-06	4.65e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—MTHFR—hypertension	6.41e-06	4.6e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—NPY—hypertension	6.35e-06	4.56e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—VWF—hypertension	6.35e-06	4.56e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—PRKCE—hypertension	6.3e-06	4.52e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—PDGFB—hypertension	6.24e-06	4.48e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—PDGFA—hypertension	6.22e-06	4.46e-05	CbGpPWpGaD
L-Citrulline—NOS1—Disease—SERPINE1—hypertension	6.21e-06	4.46e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—FGFR1—hypertension	6.21e-06	4.46e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—TGFBR2—hypertension	6.13e-06	4.4e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—CXCL2—hypertension	6.12e-06	4.4e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—OXT—hypertension	6.12e-06	4.4e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—AGTR2—hypertension	6.12e-06	4.4e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—HTR1B—hypertension	6.12e-06	4.4e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—HIF1A—hypertension	6.11e-06	4.39e-05	CbGpPWpGaD
L-Citrulline—ASS1—Metabolism—PTGS2—hypertension	6.11e-06	4.39e-05	CbGpPWpGaD
L-Citrulline—NOS2—Hemostasis—TGFB1—hypertension	6.11e-06	4.39e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—TH—hypertension	6.07e-06	4.36e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—TGFBR1—hypertension	6.05e-06	4.35e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—F2R—hypertension	6.05e-06	4.35e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—CALM2—hypertension	6.04e-06	4.34e-05	CbGpPWpGaD
L-Citrulline—NOS1—Disease—FGF2—hypertension	6.01e-06	4.32e-05	CbGpPWpGaD
L-Citrulline—NOS1—Disease—RHOA—hypertension	5.99e-06	4.3e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—CALM1—hypertension	5.99e-06	4.3e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—APOE—hypertension	5.97e-06	4.29e-05	CbGpPWpGaD
L-Citrulline—NOS1—Disease—NOS3—hypertension	5.93e-06	4.26e-05	CbGpPWpGaD
L-Citrulline—NOS1—Disease—PIK3R1—hypertension	5.93e-06	4.26e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—CAV1—hypertension	5.91e-06	4.25e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—GCG—hypertension	5.9e-06	4.24e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—SLC2A4—hypertension	5.9e-06	4.24e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—APOA1—hypertension	5.9e-06	4.24e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—NCF1—hypertension	5.86e-06	4.21e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—EDNRB—hypertension	5.86e-06	4.21e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—TAC1—hypertension	5.8e-06	4.17e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—APOB—hypertension	5.79e-06	4.16e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—GOT1—hypertension	5.72e-06	4.1e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—ANXA1—hypertension	5.69e-06	4.09e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—CXCR3—hypertension	5.69e-06	4.09e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—IKBKB—hypertension	5.64e-06	4.05e-05	CbGpPWpGaD
L-Citrulline—NOS1—Hemostasis—AKT1—hypertension	5.63e-06	4.04e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—STK11—hypertension	5.55e-06	3.98e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—CYP19A1—hypertension	5.55e-06	3.98e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—SST—hypertension	5.54e-06	3.97e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—EDNRA—hypertension	5.54e-06	3.97e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—LPL—hypertension	5.53e-06	3.97e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—CYBA—hypertension	5.51e-06	3.96e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—ADRB1—hypertension	5.51e-06	3.96e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—DRD3—hypertension	5.51e-06	3.96e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—FLT1—hypertension	5.51e-06	3.96e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—NOTCH1—hypertension	5.51e-06	3.95e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—H2AFX—hypertension	5.49e-06	3.94e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—PDGFRB—hypertension	5.48e-06	3.93e-05	CbGpPWpGaD
L-Citrulline—NOS1—Disease—MTOR—hypertension	5.47e-06	3.93e-05	CbGpPWpGaD
L-Citrulline—NOS3—Hemostasis—EP300—hypertension	5.46e-06	3.92e-05	CbGpPWpGaD
L-Citrulline—NOS1—Disease—PTGS2—hypertension	5.42e-06	3.89e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—ADRA2A—hypertension	5.42e-06	3.89e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—ADCY5—hypertension	5.41e-06	3.89e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—GHRL—hypertension	5.4e-06	3.87e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—PLAT—hypertension	5.4e-06	3.87e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—PRKCG—hypertension	5.38e-06	3.86e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—PRKCA—hypertension	5.34e-06	3.83e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—CALCA—hypertension	5.33e-06	3.83e-05	CbGpPWpGaD
L-Citrulline—ASS1—Metabolism—PTEN—hypertension	5.33e-06	3.83e-05	CbGpPWpGaD
L-Citrulline—NOS3—Hemostasis—SRC—hypertension	5.31e-06	3.81e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—YWHAZ—hypertension	5.3e-06	3.8e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—BDKRB2—hypertension	5.21e-06	3.74e-05	CbGpPWpGaD
L-Citrulline—NOS3—Hemostasis—VEGFA—hypertension	5.17e-06	3.71e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—COMT—hypertension	5.16e-06	3.7e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—ADRBK1—hypertension	5.15e-06	3.7e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—CNR1—hypertension	5.11e-06	3.67e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—INS—hypertension	5.1e-06	3.66e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—PRKCD—hypertension	5.09e-06	3.66e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—CCR5—hypertension	5.09e-06	3.66e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—GNB3—hypertension	5.09e-06	3.65e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—PPARGC1A—hypertension	5.09e-06	3.65e-05	CbGpPWpGaD
L-Citrulline—ASS1—Metabolism—EP300—hypertension	5.08e-06	3.65e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—HMOX1—hypertension	5.06e-06	3.63e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—CALM2—hypertension	5.05e-06	3.63e-05	CbGpPWpGaD
L-Citrulline—NOS2—Hemostasis—TP53—hypertension	5.03e-06	3.61e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—CAT—hypertension	5e-06	3.59e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—HTR7—hypertension	4.98e-06	3.58e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—DRD2—hypertension	4.98e-06	3.58e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—MTHFR—hypertension	4.98e-06	3.57e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—GNAS—hypertension	4.95e-06	3.56e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—PTPN1—hypertension	4.93e-06	3.54e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—GCG—hypertension	4.93e-06	3.54e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—AKT2—hypertension	4.93e-06	3.54e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—APOB—hypertension	4.85e-06	3.48e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—PDGFB—hypertension	4.85e-06	3.48e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—NOTCH2—hypertension	4.84e-06	3.47e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—KL—hypertension	4.84e-06	3.47e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—FGFR1—hypertension	4.82e-06	3.46e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—ITGAV—hypertension	4.75e-06	3.41e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—NGFR—hypertension	4.75e-06	3.41e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—HIF1A—hypertension	4.75e-06	3.41e-05	CbGpPWpGaD
L-Citrulline—NOS3—Hemostasis—TGFB1—hypertension	4.74e-06	3.4e-05	CbGpPWpGaD
L-Citrulline—NOS1—Disease—CDKN1A—hypertension	4.74e-06	3.4e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—KNG1—hypertension	4.74e-06	3.4e-05	CbGpPWpGaD
L-Citrulline—NOS1—Disease—PTEN—hypertension	4.73e-06	3.4e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—GSTM1—hypertension	4.72e-06	3.39e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—PRL—hypertension	4.71e-06	3.38e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—AGTR1—hypertension	4.71e-06	3.38e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—SERPINE1—hypertension	4.68e-06	3.36e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—CALM1—hypertension	4.65e-06	3.34e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—HDAC1—hypertension	4.64e-06	3.33e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—STK11—hypertension	4.64e-06	3.33e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—APOE—hypertension	4.63e-06	3.33e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—LPL—hypertension	4.63e-06	3.32e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—CXCL10—hypertension	4.6e-06	3.3e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—CAV1—hypertension	4.59e-06	3.3e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—PLG—hypertension	4.59e-06	3.29e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—APOA1—hypertension	4.58e-06	3.29e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—FGF2—hypertension	4.53e-06	3.26e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—ADCY5—hypertension	4.53e-06	3.25e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—RHOA—hypertension	4.52e-06	3.24e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—GPX1—hypertension	4.52e-06	3.24e-05	CbGpPWpGaD
L-Citrulline—NOS1—Disease—EP300—hypertension	4.51e-06	3.24e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—PRKCA—hypertension	4.47e-06	3.21e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—CYP1A1—hypertension	4.47e-06	3.21e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—PIK3R1—hypertension	4.47e-06	3.21e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—NOS3—hypertension	4.47e-06	3.21e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—ADRB2—hypertension	4.47e-06	3.21e-05	CbGpPWpGaD
L-Citrulline—OTC—Metabolism—AKT1—hypertension	4.43e-06	3.18e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—PRKCE—hypertension	4.41e-06	3.17e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—CD36—hypertension	4.4e-06	3.16e-05	CbGpPWpGaD
L-Citrulline—NOS1—Disease—SRC—hypertension	4.39e-06	3.15e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—VAV3—hypertension	4.35e-06	3.13e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—PDGFA—hypertension	4.35e-06	3.13e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—NOS2—hypertension	4.32e-06	3.1e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—TGFBR2—hypertension	4.29e-06	3.08e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—NOTCH1—hypertension	4.28e-06	3.07e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—GNB3—hypertension	4.25e-06	3.05e-05	CbGpPWpGaD
L-Citrulline—NOS2—Hemostasis—AKT1—hypertension	4.25e-06	3.05e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—AVP—hypertension	4.2e-06	3.01e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—MTHFR—hypertension	4.17e-06	2.99e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—GNAS—hypertension	4.14e-06	2.97e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—MTOR—hypertension	4.13e-06	2.96e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—PPARA—hypertension	4.09e-06	2.94e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—PTGS2—hypertension	4.09e-06	2.94e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—APOB—hypertension	4.06e-06	2.91e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—PTK2—hypertension	4.04e-06	2.9e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—EDN1—hypertension	3.99e-06	2.87e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—AGT—hypertension	3.96e-06	2.84e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—CCL5—hypertension	3.96e-06	2.84e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—INS—hypertension	3.96e-06	2.84e-05	CbGpPWpGaD
L-Citrulline—NOS1—Disease—MYC—hypertension	3.93e-06	2.82e-05	CbGpPWpGaD
L-Citrulline—NOS1—Disease—TGFB1—hypertension	3.92e-06	2.81e-05	CbGpPWpGaD
L-Citrulline—NOS3—Hemostasis—TP53—hypertension	3.9e-06	2.8e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—CALM1—hypertension	3.9e-06	2.8e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—APOE—hypertension	3.88e-06	2.79e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—LPL—hypertension	3.87e-06	2.78e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—CAV1—hypertension	3.85e-06	2.76e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—H2AFX—hypertension	3.84e-06	2.76e-05	CbGpPWpGaD
L-Citrulline—NOS1—Disease—EGFR—hypertension	3.84e-06	2.76e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—RPS6KB1—hypertension	3.84e-06	2.76e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—PDGFRB—hypertension	3.84e-06	2.76e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—APOA1—hypertension	3.84e-06	2.75e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—AKT2—hypertension	3.83e-06	2.75e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—ADCY5—hypertension	3.79e-06	2.72e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—PRKCG—hypertension	3.76e-06	2.7e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—ITGB3—hypertension	3.74e-06	2.68e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—PRKCA—hypertension	3.74e-06	2.68e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—YWHAZ—hypertension	3.71e-06	2.66e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—NGF—hypertension	3.67e-06	2.63e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—SPP1—hypertension	3.67e-06	2.63e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—SERPINE1—hypertension	3.64e-06	2.61e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—CDKN1A—hypertension	3.58e-06	2.57e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—CCR5—hypertension	3.57e-06	2.56e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—PRKCD—hypertension	3.57e-06	2.56e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—PTEN—hypertension	3.57e-06	2.56e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—FGF2—hypertension	3.52e-06	2.53e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—RHOA—hypertension	3.51e-06	2.52e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—HTR2A—hypertension	3.49e-06	2.51e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—C3—hypertension	3.49e-06	2.5e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—PIK3R1—hypertension	3.47e-06	2.49e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—EP300—hypertension	3.4e-06	2.44e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—PDGFB—hypertension	3.39e-06	2.44e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—PPARG—hypertension	3.38e-06	2.43e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—FGFR1—hypertension	3.38e-06	2.42e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—POMC—hypertension	3.33e-06	2.39e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—HIF1A—hypertension	3.32e-06	2.39e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—INS—hypertension	3.32e-06	2.38e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—AGT—hypertension	3.31e-06	2.38e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—SRC—hypertension	3.31e-06	2.37e-05	CbGpPWpGaD
L-Citrulline—NOS3—Hemostasis—AKT1—hypertension	3.3e-06	2.37e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—CALM1—hypertension	3.26e-06	2.34e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—LEP—hypertension	3.25e-06	2.33e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—APOE—hypertension	3.25e-06	2.33e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—CAV1—hypertension	3.22e-06	2.31e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—APOA1—hypertension	3.21e-06	2.3e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—MTOR—hypertension	3.21e-06	2.3e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—KDR—hypertension	3.18e-06	2.28e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—PTGS2—hypertension	3.18e-06	2.28e-05	CbGpPWpGaD
L-Citrulline—ASS1—Metabolism—AKT1—hypertension	3.07e-06	2.2e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—FN1—hypertension	3.06e-06	2.2e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—F2—hypertension	3.06e-06	2.2e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—PRKCB—hypertension	3.06e-06	2.2e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—ALB—hypertension	3.04e-06	2.18e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—NOTCH1—hypertension	3e-06	2.15e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—MYC—hypertension	2.96e-06	2.13e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—TGFB1—hypertension	2.96e-06	2.12e-05	CbGpPWpGaD
L-Citrulline—NOS1—Disease—IL6—hypertension	2.95e-06	2.12e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—PIK3R1—hypertension	2.91e-06	2.09e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—EGFR—hypertension	2.9e-06	2.08e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—POMC—hypertension	2.79e-06	2e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—CDKN1A—hypertension	2.78e-06	1.99e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—INS—hypertension	2.77e-06	1.99e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—PTEN—hypertension	2.77e-06	1.99e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—CCL2—hypertension	2.73e-06	1.96e-05	CbGpPWpGaD
L-Citrulline—NOS1—Disease—AKT1—hypertension	2.73e-06	1.96e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—IGF1—hypertension	2.68e-06	1.93e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—AKT2—hypertension	2.68e-06	1.92e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—PTGS2—hypertension	2.66e-06	1.91e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—EP300—hypertension	2.64e-06	1.9e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—SRC—hypertension	2.57e-06	1.84e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—SERPINE1—hypertension	2.55e-06	1.83e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—FGF2—hypertension	2.47e-06	1.77e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—RHOA—hypertension	2.46e-06	1.76e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—PIK3R1—hypertension	2.43e-06	1.75e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—PTEN—hypertension	2.32e-06	1.67e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—MYC—hypertension	2.3e-06	1.65e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—TGFB1—hypertension	2.3e-06	1.65e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—RELA—hypertension	2.29e-06	1.64e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—EGFR—hypertension	2.25e-06	1.62e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—MTOR—hypertension	2.24e-06	1.61e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—IL6—hypertension	2.23e-06	1.6e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—EP300—hypertension	2.21e-06	1.59e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—CXCL8—hypertension	2.16e-06	1.55e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—AKT1—hypertension	2.06e-06	1.48e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—MMP9—hypertension	1.95e-06	1.4e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—CDKN1A—hypertension	1.94e-06	1.4e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—PTEN—hypertension	1.94e-06	1.39e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—MAPK8—hypertension	1.9e-06	1.36e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—EP300—hypertension	1.85e-06	1.33e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—SRC—hypertension	1.8e-06	1.29e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—VEGFA—hypertension	1.75e-06	1.26e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—IL6—hypertension	1.73e-06	1.24e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—MYC—hypertension	1.61e-06	1.16e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—TGFB1—hypertension	1.61e-06	1.15e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—AKT1—hypertension	1.6e-06	1.15e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—EGFR—hypertension	1.58e-06	1.13e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—AKT1—hypertension	1.34e-06	9.6e-06	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—TP53—hypertension	1.32e-06	9.5e-06	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—IL6—hypertension	1.21e-06	8.7e-06	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—AKT1—hypertension	1.12e-06	8.02e-06	CbGpPWpGaD
